Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Gastroenterology

Validating Your Experience with IBS

At a Glance

Irritable Bowel Syndrome (IBS) is a recognized biological disorder of gut-brain interaction, not an imaginary condition caused only by stress. Modern diagnosis relies on the Rome IV criteria, which require recurrent abdominal pain linked to changes in bowel habits.

If you have spent years feeling that something is wrong with your digestion, only to be told that your tests are “normal” or that “it’s just stress,” your experience is valid. Irritable Bowel Syndrome (IBS) is not an imaginary condition; it is a recognized medical disorder with a clear biological basis [1]. Modern medicine has moved away from viewing IBS as a diagnosis of exclusion—something you are “left with” when nothing else is found—and toward a positive diagnosis based on specific symptoms and a deep understanding of how your body functions [2].

Understanding the New Standards

For many years, doctors used older guidelines (Rome III) that were broader and often included general “discomfort.” Today, experts use the Rome IV criteria, which provide a more precise and accurate diagnosis [3].

Under these modern standards, IBS is characterized by recurrent abdominal pain occurring, on average, at least one day per week over the last three months [3][4]. This pain must be associated with at least two of the following:

  • Defecation: The pain is related to having a bowel movement (it may improve or worsen after going) [1].
  • Frequency: A change in how often you have a bowel movement [3].
  • Form: A change in the appearance (form) of your stool [3].

Because these criteria are more specific, the reported global prevalence of IBS has shifted. While older estimates were higher, current research suggests that approximately 4% to 5% of people worldwide meet these rigorous Rome IV standards [5][6]. If you meet these criteria, you are part of a significant global population with a severe and distinct clinical profile [7].

The Gut-Brain Connection

IBS is now officially classified as a disorder of gut-brain interaction (DGBI) [1]. This means that the primary issue is not necessarily a “broken” part in your intestines, but rather a “communication error” between your gut and your brain.

Your digestive system and your brain are constantly talking to each other through the gut-brain axis, a complex network of nerves, hormones, and immune signals [8]. In people with IBS, this communication becomes dysregulated:

  • Altered Signaling: The signals traveling between your gut and your central nervous system can become “noisy” or distorted [8][9].
  • The Stress Response: The brain’s stress management system (the HPA axis—the hypothalamic-pituitary-adrenal system that releases stress hormones) can trigger changes in how fast food moves through your gut or how much fluid is in your intestines [10].
  • Hypervigilance: Your brain may become “hyper-aware” of what is happening in your gut, paying more attention to digestive signals that other people’s brains would normally ignore [11].

Why It Hurts: Visceral Hypersensitivity

The reason you feel pain from things that shouldn’t be painful—like normal gas or the movement of food—is a biological process called visceral hypersensitivity [12].

Think of it like a volume knob for pain that has been turned up too high. This happens through two main pathways:

  1. Peripheral Sensitization: Nerves in the lining of your gut become over-sensitive. This can be caused by small amounts of inflammation, “leaky” gut barriers, or even the activity of mast cells (immune cells that release chemicals like histamine) [13][14].
  2. Central Sensitization: Your brain and spinal cord start to amplify the signals coming from your gut [12]. Instead of your brain filtering out the sensation of digestion, it interprets those signals as intense pain or distress [13].

This is a physical, measurable biological state [12]. When you feel pain, your nerves are genuinely firing; your body is simply responding to a system that has become over-sensitized to the environment inside your gut [15][16].

Common questions in this guide

What are the Rome IV criteria for diagnosing IBS?
To meet the Rome IV criteria, you must experience recurrent abdominal pain at least one day per week on average over the last three months. This pain must be related to having a bowel movement, a change in how often you go, or a change in your stool's appearance.
What does it mean that IBS is a disorder of gut-brain interaction (DGBI)?
Classifying IBS as a DGBI means the primary issue is a communication error between your digestive system and your brain. The signals traveling along the gut-brain axis become distorted, meaning your brain misinterprets normal digestive functions as distress.
How does visceral hypersensitivity cause IBS pain?
Visceral hypersensitivity acts like a volume knob for pain that has been turned up too high in your digestive tract. Nerves in your gut become over-sensitive, and your central nervous system amplifies these signals, causing intense pain from normal digestion.
How does stress affect my IBS symptoms?
While stress doesn't mean your symptoms are imaginary, the brain's stress management system can trigger physical changes in your gut. Stress hormones can alter how fast food moves through your intestines and increase your brain's awareness of digestive signals.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my symptoms, do I meet the Rome IV criteria for an IBS diagnosis?
  2. 2.Can you explain how visceral hypersensitivity specifically contributes to the pain I am feeling?
  3. 3.Given that IBS is a disorder of gut-brain interaction, what types of treatments address this connection?
  4. 4.Are there specific 'alarm symptoms' I should watch for that would suggest my condition is not IBS?
  5. 5.How do you determine if my symptoms are caused by nerve signaling issues rather than inflammation or structural damage?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Irritable Bowel Syndrome: A Multifaceted World Still to Discover.

    Bassotti G

    Journal of clinical medicine 2022; (11(14)) doi:10.3390/jcm11144103.

    PMID: 35887869
  2. 2

    ACG Clinical Guideline: Management of Irritable Bowel Syndrome.

    Lacy BE, Pimentel M, Brenner DM, et al.

    The American journal of gastroenterology 2021; (116(1)):17-44 doi:10.14309/ajg.0000000000001036.

    PMID: 33315591
  3. 3

    Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.

    Vork L, Weerts ZZRM, Mujagic Z, et al.

    Neurogastroenterology and motility 2018; (30(2)) doi:10.1111/nmo.13189.

    PMID: 28804974
  4. 4

    Post-infection irritable bowel syndrome following Coronavirus disease-19: A systematic review and meta-analysis.

    Mathur A, Shams U, Mishra P, et al.

    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2024; (43(3)):557-566 doi:10.1007/s12664-023-01486-x.

    PMID: 38261245
  5. 5

    Rome III Versus Rome IV Criteria for Diagnosing Irritable Bowel Syndrome in a Southeast Asian Population: Insights From the Rome Foundation Global Epidemiology Study Household Survey.

    Simadibrata DM, Koo TH, Utari AP, et al.

    Journal of gastroenterology and hepatology 2026; (41(1)):168-179 doi:10.1111/jgh.70174.

    PMID: 41344821
  6. 6

    Prevalence of irritable bowel syndrome in medical students: a systematic review and meta-analysis.

    Ballena-Caicedo J, Zuzunaga-Montoya FE, Valladolid-Sandoval LAM, et al.

    Frontiers in medicine 2025; (12()):1714085 doi:10.3389/fmed.2025.1714085.

    PMID: 41473163
  7. 7

    Differences in Prevalence and Psychosocial Characteristics of Irritable Bowel Syndrome According to Rome III and Rome IV Criteria in Medical and Nursing Students.

    Park JH, Jeong HJ, Lee KE, et al.

    Journal of neurogastroenterology and motility 2024; (30(4)):491-500 doi:10.5056/jnm22067.

    PMID: 39397626
  8. 8

    Uncovering the pathophysiology of irritable bowel syndrome by exploring the gut-brain axis: a narrative review.

    Tang HY, Jiang AJ, Wang XY, et al.

    Annals of translational medicine 2021; (9(14)):1187 doi:10.21037/atm-21-2779.

    PMID: 34430628
  9. 9

    The Microbiota-Gut-Brain Axis: From Motility to Mood.

    Margolis KG, Cryan JF, Mayer EA

    Gastroenterology 2021; (160(5)):1486-1501 doi:10.1053/j.gastro.2020.10.066.

    PMID: 33493503
  10. 10

    The Place of Stress and Emotions in the Irritable Bowel Syndrome.

    Pellissier S, Bonaz B

    Vitamins and hormones 2017; (103()):327-354 doi:10.1016/bs.vh.2016.09.005.

    PMID: 28061975
  11. 11

    Attention in irritable bowel syndrome: A systematic review of affected domains and brain-gut axis interactions.

    Akbari R, Salimi Y, Dehghani-Aarani F, Rezayat E

    Journal of psychosomatic research 2025; (191()):112067 doi:10.1016/j.jpsychores.2025.112067.

    PMID: 40048890
  12. 12

    Electroacupuncture at Baliao Points Attenuates Visceral Hypersensitivity in Irritable Bowel Syndrome via Gut-Microbiota-Mast Cell-TPRV1 Axis Modulation.

    Sun MY, Xing HH, Lin X, et al.

    Neurogastroenterology and motility 2025; (37(11)):e70137 doi:10.1111/nmo.70137.

    PMID: 40887796
  13. 13

    Review article: current and future treatment approaches for pain in IBS.

    Paine P

    Alimentary pharmacology & therapeutics 2021; (54 Suppl 1()):S75-S88 doi:10.1111/apt.16550.

    PMID: 34927753
  14. 14

    Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study.

    Xu XJ, Zhang YL, Liu L, et al.

    Alimentary pharmacology & therapeutics 2017; (45(1)):100-114 doi:10.1111/apt.13848.

    PMID: 27862119
  15. 15

    Recent advances in clinical practice: mastering the challenge-managing IBS symptoms in IBD.

    Wellens J, Sabino J, Vanuytsel T, et al.

    Gut 2025; (74(2)):312-321 doi:10.1136/gutjnl-2024-333565.

    PMID: 39532478
  16. 16

    The gut-brain axis and pain signalling mechanisms in the gastrointestinal tract.

    Meerschaert KA, Chiu IM

    Nature reviews. Gastroenterology & hepatology 2025; (22(3)):206-221 doi:10.1038/s41575-024-01017-9.

    PMID: 39578592

This page provides educational information about IBS biology and diagnostic criteria. It does not replace professional medical advice or a formal evaluation by a gastroenterologist.

Get notified when new evidence is published on irritable bowel syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.